{"transactions":[{"id":729974,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-23T01:51:44.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":13562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the first anniversary of the grant date, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":13562,"derivative":{"exercise_price":31.74,"exercise_date":"2027-06-18","expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":13562},"source":{"system":"sec-edgar","filing":"0001104659-26-076570","document":"tm2618519-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1792150/000110465926076570/tm2618519-4_4seq1.xml","form_type":"4"}},{"id":731933,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T21:14:32.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":39715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":39715,"derivative":{"exercise_price":5.67,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":39715},"source":{"system":"sec-edgar","filing":"0001792150-26-000002","document":"wk-form4_1781817269.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000179215026000002/wk-form4_1781817269.xml","form_type":"4"}},{"id":731932,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T21:14:32.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":26455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program."}],"balance_after":83746,"source":{"system":"sec-edgar","filing":"0001792150-26-000002","document":"wk-form4_1781817269.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000179215026000002/wk-form4_1781817269.xml","form_type":"4"}},{"id":1103635,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T00:41:17.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":15235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program."}],"balance_after":57291,"source":{"system":"sec-edgar","filing":"0001628280-25-032728","document":"wk-form4_1750725671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828025032728/wk-form4_1750725671.xml","form_type":"4"}},{"id":1104531,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-20T23:33:08.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":15502,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15502,"derivative":{"exercise_price":24.89,"exercise_date":"2026-06-18","expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":15502},"source":{"system":"sec-edgar","filing":"0001104659-25-061270","document":"tm2518583-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1792150/000110465925061270/tm2518583-4_4seq1.xml","form_type":"4"}},{"id":1149083,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-14T23:51:14.000Z","date":"2025-04-28","kind":"grant","planned":false,"acquired":true,"shares":64457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as it vests and the shares subject to the option vest in 36 successive, equal monthly installments on each monthly anniversary of April 28, 2025, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":64457,"derivative":{"exercise_price":5.35,"expiration_date":"2035-04-28","underlying":"Common Stock","underlying_shares":64457},"source":{"system":"sec-edgar","filing":"0001628280-25-025641","document":"wk-form4_1747266667.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828025025641/wk-form4_1747266667.xml","form_type":"4"}},{"id":1149082,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-14T23:51:14.000Z","date":"2025-04-28","kind":"grant","planned":false,"acquired":true,"shares":42056,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof."}],"balance_after":42056,"source":{"system":"sec-edgar","filing":"0001628280-25-025641","document":"wk-form4_1747266667.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828025025641/wk-form4_1747266667.xml","form_type":"4"}},{"id":1163735,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-29T20:51:43.000Z","date":"2025-04-28","kind":"grant","planned":false,"acquired":true,"shares":28346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest annually in equal installments over three years, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":28346,"derivative":{"exercise_price":20.92,"expiration_date":"2035-04-27","underlying":"Common Stock","underlying_shares":28346},"source":{"system":"sec-edgar","filing":"0001104659-25-041344","document":"tm2513488-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1792150/000110465925041344/tm2513488-2_4seq1.xml","form_type":"4"}},{"id":328470,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-12T00:24:27.000Z","date":"2024-12-10","kind":"exercise","planned":false,"acquired":false,"shares":3820,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":36753,"derivative":{"underlying":"Common Stock","underlying_shares":3820},"source":{"system":"sec-edgar","filing":"0001127602-24-029171","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029171/form4.xml","form_type":"4"}},{"id":328469,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-12T00:24:27.000Z","date":"2024-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1771,"price":92.34,"value":163534.14,"ownership":{"direct":true},"balance_after":82850,"source":{"system":"sec-edgar","filing":"0001127602-24-029171","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029171/form4.xml","form_type":"4"}},{"id":328468,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-12T00:24:27.000Z","date":"2024-12-10","kind":"exercise","planned":false,"acquired":true,"shares":3820,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":84621,"source":{"system":"sec-edgar","filing":"0001127602-24-029171","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029171/form4.xml","form_type":"4"}},{"id":328838,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-11-30T01:10:23.000Z","date":"2024-11-27","kind":"exercise","planned":true,"acquired":false,"shares":88119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option have a four-year vesting schedule.  25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":196,"derivative":{"exercise_price":65.38,"expiration_date":"2029-11-10","underlying":"Common Stock","underlying_shares":88119},"source":{"system":"sec-edgar","filing":"0001127602-24-028232","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028232/form4.xml","form_type":"4"}},{"id":328837,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-11-30T01:10:23.000Z","date":"2024-11-27","kind":"exercise","planned":true,"acquired":false,"shares":57294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option have a four-year vesting schedule.  25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":64376,"derivative":{"exercise_price":57.92,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":57294},"source":{"system":"sec-edgar","filing":"0001127602-24-028232","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028232/form4.xml","form_type":"4"}},{"id":328836,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-11-30T01:10:23.000Z","date":"2024-11-27","kind":"sale","planned":true,"acquired":false,"shares":10399,"price":92,"value":956708.0,"ownership":{"direct":true},"balance_after":80801,"source":{"system":"sec-edgar","filing":"0001127602-24-028232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028232/form4.xml","form_type":"4"}},{"id":328835,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-11-30T01:10:23.000Z","date":"2024-11-27","kind":"sale","planned":true,"acquired":false,"shares":3199,"price":91.8034,"value":293679.0766,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $91.451 to $92.035. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":91200,"source":{"system":"sec-edgar","filing":"0001127602-24-028232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028232/form4.xml","form_type":"4"}},{"id":328834,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-11-30T01:10:23.000Z","date":"2024-11-27","kind":"sale","planned":true,"acquired":false,"shares":5200,"price":91.8041,"value":477381.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices reported for the transactions reported here range from $91.458 to $92.04. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":94399,"source":{"system":"sec-edgar","filing":"0001127602-24-028232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028232/form4.xml","form_type":"4"}},{"id":328833,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-11-30T01:10:23.000Z","date":"2024-11-27","kind":"sale","planned":true,"acquired":false,"shares":88119,"price":92,"value":8106948.0,"ownership":{"direct":true},"balance_after":99599,"source":{"system":"sec-edgar","filing":"0001127602-24-028232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028232/form4.xml","form_type":"4"}},{"id":328832,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-11-30T01:10:23.000Z","date":"2024-11-27","kind":"sale","planned":true,"acquired":false,"shares":57294,"price":91.7949,"value":5259297.0006,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale prices reported for the transactions reported here range from $91.451 to $92.095.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":187718,"source":{"system":"sec-edgar","filing":"0001127602-24-028232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028232/form4.xml","form_type":"4"}},{"id":328831,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-11-30T01:10:23.000Z","date":"2024-11-27","kind":"exercise","planned":true,"acquired":true,"shares":88119,"price":65.38,"value":5761220.22,"ownership":{"direct":true},"balance_after":245012,"source":{"system":"sec-edgar","filing":"0001127602-24-028232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028232/form4.xml","form_type":"4"}},{"id":328830,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-11-30T01:10:23.000Z","date":"2024-11-27","kind":"exercise","planned":true,"acquired":true,"shares":57294,"price":57.92,"value":3318468.48,"ownership":{"direct":true},"balance_after":156893,"source":{"system":"sec-edgar","filing":"0001127602-24-028232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028232/form4.xml","form_type":"4"}},{"id":329612,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-11-07T21:32:29.000Z","date":"2024-11-06","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on November 9, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a four-year vesting schedule.  25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":121670,"derivative":{"exercise_price":57.92,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001127602-24-026735","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224026735/form4.xml","form_type":"4"}},{"id":329611,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-11-07T21:32:29.000Z","date":"2024-11-06","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":91.5,"value":457500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on November 9, 2023."}],"balance_after":99599,"source":{"system":"sec-edgar","filing":"0001127602-24-026735","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224026735/form4.xml","form_type":"4"}},{"id":329610,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-11-07T21:32:29.000Z","date":"2024-11-06","kind":"sale","planned":true,"acquired":false,"shares":20590,"price":91.5,"value":1883985.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on November 9, 2023."}],"balance_after":104599,"source":{"system":"sec-edgar","filing":"0001127602-24-026735","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224026735/form4.xml","form_type":"4"}},{"id":329609,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-11-07T21:32:29.000Z","date":"2024-11-06","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":57.92,"value":1448000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on November 9, 2023."}],"balance_after":125189,"source":{"system":"sec-edgar","filing":"0001127602-24-026735","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224026735/form4.xml","form_type":"4"}},{"id":330332,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-10-02T20:58:23.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":83.83,"value":167660.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on November 9, 2023."}],"balance_after":100189,"source":{"system":"sec-edgar","filing":"0001127602-24-024958","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224024958/form4.xml","form_type":"4"}},{"id":330774,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-09-13T23:07:56.000Z","date":"2024-09-12","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on November 9, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a four-year vesting schedule.  25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":146670,"derivative":{"exercise_price":57.92,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001127602-24-023946","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023946/form4.xml","form_type":"4"}},{"id":330773,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-09-13T23:07:56.000Z","date":"2024-09-12","kind":"sale","planned":true,"acquired":false,"shares":21246,"price":84.5,"value":1795287.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on November 9, 2023."}],"balance_after":102189,"source":{"system":"sec-edgar","filing":"0001127602-24-023946","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023946/form4.xml","form_type":"4"}},{"id":330772,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-09-13T23:07:56.000Z","date":"2024-09-12","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":57.92,"value":1448000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on November 9, 2023."}],"balance_after":123435,"source":{"system":"sec-edgar","filing":"0001127602-24-023946","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023946/form4.xml","form_type":"4"}},{"id":330826,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-09-11T23:33:56.000Z","date":"2024-09-10","kind":"exercise","planned":false,"acquired":false,"shares":3821,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":40573,"derivative":{"underlying":"Common Stock","underlying_shares":3821},"source":{"system":"sec-edgar","filing":"0001127602-24-023821","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023821/form4.xml","form_type":"4"}},{"id":330825,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-09-11T23:33:56.000Z","date":"2024-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1766,"price":81.44,"value":143823.04,"ownership":{"direct":true},"balance_after":98435,"source":{"system":"sec-edgar","filing":"0001127602-24-023821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023821/form4.xml","form_type":"4"}},{"id":330824,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-09-11T23:33:56.000Z","date":"2024-09-10","kind":"exercise","planned":false,"acquired":true,"shares":3821,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":100201,"source":{"system":"sec-edgar","filing":"0001127602-24-023821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023821/form4.xml","form_type":"4"}},{"id":332447,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-07-02T00:06:29.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":68.63,"value":137260.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on November 9, 2023."}],"balance_after":96380,"source":{"system":"sec-edgar","filing":"0001127602-24-019650","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224019650/form4.xml","form_type":"4"}},{"id":332914,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-06-11T23:15:14.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":false,"shares":3820,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":44394,"derivative":{"underlying":"Common Stock","underlying_shares":3820},"source":{"system":"sec-edgar","filing":"0001127602-24-018413","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224018413/form4.xml","form_type":"4"}},{"id":332913,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-11T23:15:14.000Z","date":"2024-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1744,"price":65.25,"value":113796.0,"ownership":{"direct":true},"balance_after":98380,"source":{"system":"sec-edgar","filing":"0001127602-24-018413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224018413/form4.xml","form_type":"4"}},{"id":332912,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-11T23:15:14.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":true,"shares":3820,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":100124,"source":{"system":"sec-edgar","filing":"0001127602-24-018413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224018413/form4.xml","form_type":"4"}},{"id":1486281,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:07:02.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":51459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 5, 2024, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":51459,"derivative":{"exercise_price":4.64,"expiration_date":"2034-06-04","underlying":"Series A Common Stock","underlying_shares":51459},"source":{"system":"sec-edgar","filing":"0001104659-24-069636","document":"tm2416701-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465924069636/tm2416701-3_4seq1.xml","form_type":"4"}},{"id":335924,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-04-02T22:38:27.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":72.96,"value":145920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on November 9, 2023."}],"balance_after":96304,"source":{"system":"sec-edgar","filing":"0001127602-24-011987","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224011987/form4.xml","form_type":"4"}},{"id":337814,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-03-12T01:14:09.000Z","date":"2024-03-10","kind":"grant","planned":false,"acquired":true,"shares":17640,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":48214,"derivative":{"underlying":"Common Stock","underlying_shares":17640},"source":{"system":"sec-edgar","filing":"0001127602-24-009546","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009546/form4.xml","form_type":"4"}},{"id":337813,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-03-12T01:14:09.000Z","date":"2024-03-10","kind":"grant","planned":false,"acquired":true,"shares":89660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option have a four-year vesting schedule.  25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":89660,"derivative":{"exercise_price":75.12,"expiration_date":"2034-03-10","underlying":"Common Stock","underlying_shares":89660},"source":{"system":"sec-edgar","filing":"0001127602-24-009546","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009546/form4.xml","form_type":"4"}},{"id":337812,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-03-12T01:14:09.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":false,"shares":6946,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":30574,"derivative":{"underlying":"Common Stock","underlying_shares":6946},"source":{"system":"sec-edgar","filing":"0001127602-24-009546","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009546/form4.xml","form_type":"4"}},{"id":337811,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-03-12T01:14:09.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":false,"shares":3455,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":37520,"derivative":{"underlying":"Common Stock","underlying_shares":3455},"source":{"system":"sec-edgar","filing":"0001127602-24-009546","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009546/form4.xml","form_type":"4"}},{"id":337810,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-03-12T01:14:09.000Z","date":"2024-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4803,"price":75.12,"value":360801.36,"ownership":{"direct":true},"balance_after":98304,"source":{"system":"sec-edgar","filing":"0001127602-24-009546","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009546/form4.xml","form_type":"4"}},{"id":337809,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-03-12T01:14:09.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":true,"shares":6946,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":103107,"source":{"system":"sec-edgar","filing":"0001127602-24-009546","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009546/form4.xml","form_type":"4"}},{"id":337808,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-03-12T01:14:09.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":true,"shares":3455,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":96161,"source":{"system":"sec-edgar","filing":"0001127602-24-009546","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009546/form4.xml","form_type":"4"}},{"id":338694,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-29T23:35:55.000Z","date":"2024-02-29","kind":"sale","planned":true,"acquired":false,"shares":8230,"price":72.7368,"value":598623.864,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on November 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices reported for the transactions reported here range from $72.454 to $72.88. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."}],"balance_after":92706,"source":{"system":"sec-edgar","filing":"0001127602-24-007678","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224007678/form4.xml","form_type":"4"}},{"id":338693,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-29T23:35:55.000Z","date":"2024-02-28","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":73.18,"value":146360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on November 9, 2023."}],"balance_after":100936,"source":{"system":"sec-edgar","filing":"0001127602-24-007678","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224007678/form4.xml","form_type":"4"}},{"id":341384,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-02T19:42:05.000Z","date":"2024-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":23709,"price":78.26,"value":1855466.34,"ownership":{"direct":true},"balance_after":102616,"source":{"system":"sec-edgar","filing":"0001127602-24-003044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224003044/form4.xml","form_type":"4"}},{"id":341383,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-02T19:42:05.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":56624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2021. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors."}],"balance_after":126325,"source":{"system":"sec-edgar","filing":"0001127602-24-003044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224003044/form4.xml","form_type":"4"}},{"id":341382,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-02T19:42:05.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":20229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2022 and March 10, 2023. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met."}],"balance_after":69701,"source":{"system":"sec-edgar","filing":"0001127602-24-003044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224003044/form4.xml","form_type":"4"}},{"id":343786,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-12-12T00:10:54.000Z","date":"2023-12-10","kind":"exercise","planned":false,"acquired":false,"shares":2779,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":40975,"derivative":{"underlying":"Common Stock","underlying_shares":2779},"source":{"system":"sec-edgar","filing":"0001127602-23-029247","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223029247/form4.xml","form_type":"4"}},{"id":343785,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-12T00:10:54.000Z","date":"2023-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1269,"price":79.02,"value":100276.38,"ownership":{"direct":true},"balance_after":71640,"source":{"system":"sec-edgar","filing":"0001127602-23-029247","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223029247/form4.xml","form_type":"4"}},{"id":343784,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-12T00:10:54.000Z","date":"2023-12-10","kind":"exercise","planned":false,"acquired":true,"shares":2779,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":72909,"source":{"system":"sec-edgar","filing":"0001127602-23-029247","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223029247/form4.xml","form_type":"4"}},{"id":345860,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-09-13T22:50:26.000Z","date":"2023-09-12","kind":"sale","planned":true,"acquired":false,"shares":1501,"price":76.99,"value":115561.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on November 30, 2022."}],"balance_after":70130,"source":{"system":"sec-edgar","filing":"0001127602-23-024115","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223024115/form4.xml","form_type":"4"}},{"id":345911,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-09-12T00:19:06.000Z","date":"2023-09-10","kind":"exercise","planned":false,"acquired":false,"shares":2779,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":43754,"derivative":{"underlying":"Common Stock","underlying_shares":2779},"source":{"system":"sec-edgar","filing":"0001127602-23-023979","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223023979/form4.xml","form_type":"4"}},{"id":345910,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-09-12T00:19:06.000Z","date":"2023-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1278,"price":76,"value":97128.0,"ownership":{"direct":true},"balance_after":71631,"source":{"system":"sec-edgar","filing":"0001127602-23-023979","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223023979/form4.xml","form_type":"4"}},{"id":345909,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-09-12T00:19:06.000Z","date":"2023-09-10","kind":"exercise","planned":false,"acquired":true,"shares":2779,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":72909,"source":{"system":"sec-edgar","filing":"0001127602-23-023979","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223023979/form4.xml","form_type":"4"}},{"id":1825577,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:52.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":23839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":23839,"derivative":{"exercise_price":6.36,"expiration_date":"2031-01-26","underlying":"Series A Common Stock","underlying_shares":23839},"source":{"system":"sec-edgar","filing":"0001104659-23-082729","document":"tm2321276-18_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082729/tm2321276-18_4seq1.xml","form_type":"4"}},{"id":1825576,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:52.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":6.36,"expiration_date":"2031-01-26","underlying":"Common Stock","underlying_shares":23839},"source":{"system":"sec-edgar","filing":"0001104659-23-082729","document":"tm2321276-18_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082729/tm2321276-18_4seq1.xml","form_type":"4"}},{"id":1825575,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:52.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":23216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":23216,"derivative":{"exercise_price":6.36,"expiration_date":"2029-04-27","underlying":"Series A Common Stock","underlying_shares":23216},"source":{"system":"sec-edgar","filing":"0001104659-23-082729","document":"tm2321276-18_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082729/tm2321276-18_4seq1.xml","form_type":"4"}},{"id":1825574,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:52.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":6.36,"expiration_date":"2029-04-27","underlying":"Common Stock","underlying_shares":23216},"source":{"system":"sec-edgar","filing":"0001104659-23-082729","document":"tm2321276-18_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082729/tm2321276-18_4seq1.xml","form_type":"4"}},{"id":1825573,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:52.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":144,"derivative":{"exercise_price":23.05,"expiration_date":"2025-02-05","underlying":"Series A Common Stock","underlying_shares":144},"source":{"system":"sec-edgar","filing":"0001104659-23-082729","document":"tm2321276-18_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082729/tm2321276-18_4seq1.xml","form_type":"4"}},{"id":1825572,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:52.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":23.05,"expiration_date":"2025-02-05","underlying":"Common Stock","underlying_shares":144},"source":{"system":"sec-edgar","filing":"0001104659-23-082729","document":"tm2321276-18_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082729/tm2321276-18_4seq1.xml","form_type":"4"}},{"id":1825571,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:52.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":3349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":3349,"derivative":{"exercise_price":23.05,"expiration_date":"2024-12-16","underlying":"Series A Common Stock","underlying_shares":3349},"source":{"system":"sec-edgar","filing":"0001104659-23-082729","document":"tm2321276-18_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082729/tm2321276-18_4seq1.xml","form_type":"4"}},{"id":1825570,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:52.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":23.05,"expiration_date":"2024-12-16","underlying":"Common Stock","underlying_shares":3349},"source":{"system":"sec-edgar","filing":"0001104659-23-082729","document":"tm2321276-18_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082729/tm2321276-18_4seq1.xml","form_type":"4"}},{"id":1825569,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:52.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":2086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":2086,"derivative":{"exercise_price":11.13,"expiration_date":"2024-03-12","underlying":"Series A Common Stock","underlying_shares":2086},"source":{"system":"sec-edgar","filing":"0001104659-23-082729","document":"tm2321276-18_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082729/tm2321276-18_4seq1.xml","form_type":"4"}},{"id":1825568,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:52.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":11.13,"expiration_date":"2024-03-12","underlying":"Common Stock","underlying_shares":2086},"source":{"system":"sec-edgar","filing":"0001104659-23-082729","document":"tm2321276-18_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082729/tm2321276-18_4seq1.xml","form_type":"4"}},{"id":1825567,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series E Preferred Stock","published_at":"2023-07-20T20:17:52.000Z","date":"2023-07-18","kind":"exercise","planned":false,"acquired":false,"shares":327309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Upon closing of the Issuer's initial public offering, each share of Series E Preferred Stock automatically converted on a 79.4784-to-one basis into shares of the Issuer's Series A Common Stock. The Series E Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."}],"balance_after":0,"derivative":{"underlying":"Series A Common Stock","underlying_shares":4117},"source":{"system":"sec-edgar","filing":"0001104659-23-082729","document":"tm2321276-18_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082729/tm2321276-18_4seq1.xml","form_type":"4"}},{"id":1825566,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Stock","published_at":"2023-07-20T20:17:52.000Z","date":"2023-07-18","kind":"exercise","planned":false,"acquired":true,"shares":4117,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Upon closing of the Issuer's initial public offering, each share of Series E Preferred Stock automatically converted on a 79.4784-to-one basis into shares of the Issuer's Series A Common Stock. The Series E Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon closing of the Issuer's initial public offering, each share of Series E Preferred Stock automatically converted on a 79.4784-to-one basis into shares of the Issuer's Series A Common Stock. The Series E Preferred Stock had no expiration date."}],"balance_after":12794,"source":{"system":"sec-edgar","filing":"0001104659-23-082729","document":"tm2321276-18_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082729/tm2321276-18_4seq1.xml","form_type":"4"}},{"id":1825565,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Stock","published_at":"2023-07-20T20:17:52.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":8677,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."}],"balance_after":8677,"source":{"system":"sec-edgar","filing":"0001104659-23-082729","document":"tm2321276-18_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082729/tm2321276-18_4seq1.xml","form_type":"4"}},{"id":1825564,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-20T20:17:52.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8677,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-23-082729","document":"tm2321276-18_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082729/tm2321276-18_4seq1.xml","form_type":"4"}},{"id":348300,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-06-14T21:48:50.000Z","date":"2023-06-13","kind":"sale","planned":true,"acquired":false,"shares":1485,"price":76.9,"value":114196.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on November 30, 2022."}],"balance_after":29402,"source":{"system":"sec-edgar","filing":"0001127602-23-018727","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223018727/form4.xml","form_type":"4"}},{"id":348344,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-06-12T20:45:50.000Z","date":"2023-06-10","kind":"exercise","planned":false,"acquired":false,"shares":2779,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":46533,"derivative":{"underlying":"Common Stock","underlying_shares":2779},"source":{"system":"sec-edgar","filing":"0001127602-23-018588","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223018588/form4.xml","form_type":"4"}},{"id":348343,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-06-12T20:45:50.000Z","date":"2023-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1294,"price":78.12,"value":101087.28,"ownership":{"direct":true},"balance_after":30887,"source":{"system":"sec-edgar","filing":"0001127602-23-018588","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223018588/form4.xml","form_type":"4"}},{"id":348342,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-06-12T20:45:50.000Z","date":"2023-06-10","kind":"exercise","planned":false,"acquired":true,"shares":2779,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":32181,"source":{"system":"sec-edgar","filing":"0001127602-23-018588","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223018588/form4.xml","form_type":"4"}},{"id":351257,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-14T22:20:38.000Z","date":"2023-03-13","kind":"sale","acquired":false,"shares":6126,"price":78.99,"value":483892.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":70130,"source":{"system":"sec-edgar","filing":"0001127602-23-010126","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223010126/form4.xml","form_type":"4"}},{"id":351507,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2023-03-14T01:09:50.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":76000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":76000,"derivative":{"exercise_price":79.5,"expiration_date":"2033-03-10","underlying":"Common Stock","underlying_shares":76000},"source":{"system":"sec-edgar","filing":"0001127602-23-009986","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009986/form4.xml","form_type":"4"}},{"id":351506,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-03-14T01:09:50.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":16665,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":49312,"derivative":{"underlying":"Common Stock","underlying_shares":16665},"source":{"system":"sec-edgar","filing":"0001127602-23-009986","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009986/form4.xml","form_type":"4"}},{"id":351505,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-03-14T01:09:50.000Z","date":"2023-03-10","kind":"exercise","acquired":false,"shares":7999,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":32647,"derivative":{"underlying":"Common Stock","underlying_shares":7999},"source":{"system":"sec-edgar","filing":"0001127602-23-009986","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009986/form4.xml","form_type":"4"}},{"id":351504,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-03-14T01:09:50.000Z","date":"2023-03-10","kind":"exercise","acquired":false,"shares":3455,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":40646,"derivative":{"underlying":"Common Stock","underlying_shares":3455},"source":{"system":"sec-edgar","filing":"0001127602-23-009986","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009986/form4.xml","form_type":"4"}},{"id":351503,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-14T01:09:50.000Z","date":"2023-03-10","kind":"tax_withholding","acquired":false,"shares":5328,"price":79.5,"value":423576.0,"ownership":{"direct":true},"balance_after":76256,"source":{"system":"sec-edgar","filing":"0001127602-23-009986","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009986/form4.xml","form_type":"4"}},{"id":351502,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-14T01:09:50.000Z","date":"2023-03-10","kind":"exercise","acquired":true,"shares":7999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":81584,"source":{"system":"sec-edgar","filing":"0001127602-23-009986","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009986/form4.xml","form_type":"4"}},{"id":351501,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-14T01:09:50.000Z","date":"2023-03-10","kind":"exercise","acquired":true,"shares":3455,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":73585,"source":{"system":"sec-edgar","filing":"0001127602-23-009986","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009986/form4.xml","form_type":"4"}},{"id":352029,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-03T00:01:10.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":12984,"price":79.9619,"value":1038225.3096,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices reported for the transactions reported here range from $79.60 to $80.34.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":70130,"source":{"system":"sec-edgar","filing":"0001127602-23-008491","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223008491/form4.xml","form_type":"4"}},{"id":352651,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-23T21:16:52.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":376,"price":56.3805,"value":21199.068,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Gilead Sciences, Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of August 16, 2022 through February 15, 2023.  This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 16, 2022."}],"balance_after":83114,"source":{"system":"sec-edgar","filing":"0001127602-23-006763","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223006763/form4.xml","form_type":"4"}},{"id":354527,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-26T20:40:56.000Z","date":"2023-01-24","kind":"tax_withholding","acquired":false,"shares":17749,"price":84.02,"value":1491270.98,"ownership":{"direct":true},"balance_after":82738,"source":{"system":"sec-edgar","filing":"0001127602-23-002286","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223002286/form4.xml","form_type":"4"}},{"id":354526,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-26T20:40:56.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":43715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on March 10, 2020. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors."}],"balance_after":100487,"source":{"system":"sec-edgar","filing":"0001127602-23-002286","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223002286/form4.xml","form_type":"4"}},{"id":354525,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-26T20:40:56.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":29644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2021 and March 10, 2022. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met."}],"balance_after":56772,"source":{"system":"sec-edgar","filing":"0001127602-23-002286","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223002286/form4.xml","form_type":"4"}},{"id":355542,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-04T01:05:19.000Z","date":"2022-12-30","kind":"sale","acquired":false,"shares":553,"price":85.33,"value":47187.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":45556,"source":{"system":"sec-edgar","filing":"0001127602-23-000216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223000216/form4.xml","form_type":"4"}},{"id":355946,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-12-13T20:14:10.000Z","date":"2022-12-10","kind":"exercise","acquired":false,"shares":1039,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":44101,"derivative":{"underlying":"Common Stock","underlying_shares":1039},"source":{"system":"sec-edgar","filing":"0001127602-22-027389","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222027389/form4.xml","form_type":"4"}},{"id":355945,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-13T20:14:10.000Z","date":"2022-12-10","kind":"tax_withholding","acquired":false,"shares":486,"price":87.97,"value":42753.42,"ownership":{"direct":true},"balance_after":46109,"source":{"system":"sec-edgar","filing":"0001127602-22-027389","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222027389/form4.xml","form_type":"4"}},{"id":355944,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-13T20:14:10.000Z","date":"2022-12-10","kind":"exercise","acquired":true,"shares":1039,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":46595,"source":{"system":"sec-edgar","filing":"0001127602-22-027389","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222027389/form4.xml","form_type":"4"}},{"id":356667,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-11-14T17:42:18.000Z","date":"2022-11-10","kind":"exercise","acquired":false,"shares":5099,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":45140,"derivative":{"underlying":"Common Stock","underlying_shares":5099},"source":{"system":"sec-edgar","filing":"0001127602-22-025411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222025411/form4.xml","form_type":"4"}},{"id":356666,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-11-14T17:42:18.000Z","date":"2022-11-10","kind":"tax_withholding","acquired":false,"shares":2268,"price":82.6,"value":187336.8,"ownership":{"direct":true},"balance_after":45556,"source":{"system":"sec-edgar","filing":"0001127602-22-025411","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222025411/form4.xml","form_type":"4"}},{"id":356665,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-11-14T17:42:18.000Z","date":"2022-11-10","kind":"exercise","acquired":true,"shares":5099,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":47824,"source":{"system":"sec-edgar","filing":"0001127602-22-025411","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222025411/form4.xml","form_type":"4"}},{"id":358175,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-09-12T20:05:34.000Z","date":"2022-09-10","kind":"exercise","acquired":false,"shares":1039,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":50239,"derivative":{"underlying":"Common Stock","underlying_shares":1039},"source":{"system":"sec-edgar","filing":"0001127602-22-022290","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222022290/form4.xml","form_type":"4"}},{"id":358174,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-09-12T20:05:34.000Z","date":"2022-09-10","kind":"tax_withholding","acquired":false,"shares":481,"price":65.28,"value":31399.68,"ownership":{"direct":true},"balance_after":42725,"source":{"system":"sec-edgar","filing":"0001127602-22-022290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222022290/form4.xml","form_type":"4"}},{"id":358173,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-09-12T20:05:34.000Z","date":"2022-09-10","kind":"exercise","acquired":true,"shares":1039,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":43206,"source":{"system":"sec-edgar","filing":"0001127602-22-022290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222022290/form4.xml","form_type":"4"}},{"id":360422,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-06-13T23:53:27.000Z","date":"2022-06-10","kind":"exercise","acquired":false,"shares":1039,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":51278,"derivative":{"underlying":"Common Stock","underlying_shares":1039},"source":{"system":"sec-edgar","filing":"0001127602-22-017322","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222017322/form4.xml","form_type":"4"}},{"id":360421,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-06-13T23:53:27.000Z","date":"2022-06-10","kind":"tax_withholding","acquired":false,"shares":485,"price":60.74,"value":29458.9,"ownership":{"direct":true},"balance_after":42167,"source":{"system":"sec-edgar","filing":"0001127602-22-017322","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222017322/form4.xml","form_type":"4"}},{"id":360420,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15164,"kind":"person","name":"Parsey Merdad","position":1,"cik":"0001792150","reported_name":"Parsey Merdad","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-06-13T23:53:27.000Z","date":"2022-06-10","kind":"exercise","acquired":true,"shares":1039,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":42652,"source":{"system":"sec-edgar","filing":"0001127602-22-017322","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222017322/form4.xml","form_type":"4"}}],"next_cursor":"2022-06-13T23:53:27.000000Z,360420"}